2011 - 2020 of 5662 Results
Title
Year
-
OPENTitle: Dysregulation of the AP2M1 phosphorylation cycle by LRRK2 impairs endocytosis and leads to dopaminergic neurodegenerationJournal Name: Science SignalingPublisher: American Association for the Advancement of Science (AAAS)Vol: 14Issue #: 693Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1126/scisignal.abg3555Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8486338Citation Count: 17
-
OPENTitle: Olfaction, cholinergic basal forebrain degeneration, and cognition in early Parkinson diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 90Issue #:Start Page: 27End Page: 32Publication Date:Open Access(OA) Status: OPENLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.07.024Best OA location URL: http://manuscript.elsevier.com/S135380202100273X/pdf/S135380202100273X.pdfCitation Count: 10
-
OPENTitle: A glutaminyl cyclase-catalyzed α-synuclein modification identified in human synucleinopathiesJournal Name: Acta NeuropathologicaPublisher: Springer Science and Business Media LLCVol: 142Issue #: 3Start Page: 399End Page: 421Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s00401-021-02349-5Best OA location URL: https://link.springer.com/content/pdf/10.1007/s00401-021-02349-5.pdfCitation Count: 17
-
OPENTitle: Distinct progression patterns across Parkinson disease clinical subtypesJournal Name: Annals of Clinical and Translational NeurologyPublisher: WileyVol: 8Issue #: 8Start Page: 1695End Page: 1708Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/acn3.51436Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/acn3.51436Citation Count: 6
-
OPENTitle: Genetic risk, adherence to a healthy lifestyle, and cognitive decline in African Americans and European AmericansJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 18Issue #: 4Start Page: 572End Page: 580Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/alz.12435Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8789942Citation Count: 20
-
OPENTitle: A high dose tango intervention for people with Parkinson's disease (PwPD)Journal Name: Advances in Integrative MedicinePublisher: Elsevier BVVol: 8Issue #: 4Start Page: 272End Page: 277Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.aimed.2021.07.005Best OA location URL: https://www.biorxiv.org/content/biorxiv/early/2019/04/18/613661.full.pdfCitation Count: 4
-
OPENTitle: Rationale and design to evaluate the PRIME Parkinson care model: a prospective observational evaluation of proactive, integrated and patient-centred Parkinson care in The Netherlands (PRIME-NL)Journal Name: BMC NeurologyPublisher: Springer Science and Business Media LLCVol: 21Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s12883-021-02308-3Best OA location URL: https://bmcneurol.biomedcentral.com/track/pdf/10.1186/s12883-021-02308-3Citation Count: 23
-
OPENTitle: Dysregulation of the Adaptive Immune System in Patients With Early-Stage Parkinson DiseaseJournal Name: Neurology Neuroimmunology & NeuroinflammationPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 8Issue #: 5Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1212/nxi.0000000000001036Best OA location URL: https://nn.neurology.org/content/nnn/8/5/e1036.full.pdfCitation Count: 67
-
OPENTitle: Rivastigmine for minor visual hallucinations in Parkinson's disease: A randomized controlled trial with 24 months follow‐upJournal Name: Brain and BehaviorPublisher: WileyVol: 11Issue #: 8Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/brb3.2257Best OA location URL: https://doi.org/10.1002/brb3.2257Citation Count: 11
-
OPENTitle: Rosmarinic Acid Potently Detoxifies Amylin Amyloid and Ameliorates Diabetic Pathology in a Transgenic Rat Model of Type 2 DiabetesJournal Name: ACS Pharmacology & Translational SciencePublisher: American Chemical Society (ACS)Vol: 4Issue #: 4Start Page: 1322End Page: 1337Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1021/acsptsci.1c00028Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8369672Citation Count: 14